Investor Relations

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Our lead combination product candidates targeted for obesity are Contrave^® (bupropion SR/naltrexone SR), which has completed Phase 3 clinical trials, and Empatic™ (zonisamide SR/bupropion SR), which is in the later stages of Phase 2 More >>

Stock Quote OREX (Common Stock) Exchange NASDAQ (US Dollar) Price $2.76 Change (%)   0.18 (6.98%) Volume 705,001 Jan 27, 2012 3:59 p.m. ET Minimum 20 minute delay Refresh quote

Interactive Company Calendar January 2012 ? Calendar Help This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser. Calendar Icon Legend: Analyst Meeting Conference Conference Presentation Corporate Conference Call Custom Events Earnings Conference Call Earnings Release Financial Reports Mergers & Acquisition Announcement Guidance Announcement Other Corporate Sales Call/Presentation Sales Release Shareholders Meeting News Release SEC Filings Presentations 52 Week High ‹ Today › Sun Mon Tue Wed Thu Fri Sat 1 2 3 4 5 01/05/12 Orexigen Therapeutics to Present at the J.P. Morgan Healthcare Conference 6 7 8 9 10 01/10/12 8-K Formats:     11 12 01/12/12 Orexigen Therapeutics, Inc. at JPMorgan Global Healthcare Conference 13 01/13/12 SC 13D/A Formats:     14 15 16 17 01/17/12 3 Formats:     18 19 20 21 22 23 24 25 26 27 28 29 30 31 51 52 53 54

Date Title   01/05/12 Orexigen Therapeutics to Present at the J.P. Morgan Healthcare Conference 12/22/11 Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock 12/15/11 Orexigen® Therapeutics Prices Public Offering of Common Stock and Warrants to Purchase Common Stock 12/14/11 Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.